Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-19-001966
Filing Date
2019-03-15
Accepted
2019-03-15 16:22:07
Documents
91
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT admp-10k_123118.htm 10-K 1442598
2 CONSENT OF MAYER HOFFMAN MCCANN P.C. ex23-1.htm EX-32.1 4324
3 CERTIFICATION BY CEO PURSUANT TO SECTION 302 ex31-1.htm EX-31.1 14729
4 CERTIFICATION BY CFO PURSUANT TO SECTION 302 ex31-2.htm EX-31.2 14769
5 CERTIFICATION BY CEO PURSUANT TO SECTION 906 ex32-1.htm EX-32.1 7236
6 CERTIFICATION BY CFO PURSUANT TO SECTION 906 ex32-2.htm EX-32.2 7103
  Complete submission text file 0001387131-19-001966.txt   5949057

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT admp-20181231.xml EX-101.INS 994457
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20181231.xsd EX-101.SCH 56956
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20181231_cal.xml EX-101.CAL 91876
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20181231_def.xml EX-101.DEF 228696
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20181231_lab.xml EX-101.LAB 440601
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20181231_pre.xml EX-101.PRE 354559
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36242 | Film No.: 19685320
SIC: 2834 Pharmaceutical Preparations